XPeng (09868.HK), KEYMED BIO-B (02162.HK) IPOs Over-subscribed by 1.4x, 69x
XPeng (09868.HK), KEYMED BIO-B (02162.HK) IPOs Over-subscribed by 1.4x, 69x
XPeng(09868.HK)、KeyMed BIO-B(02162.HK)IPO超額認購1.4倍、69倍
Brokers have so far granted $1.83 billion margin to the IPO of XPeng (09868.HK)(XPEV.US) on the first day of public offering as at around 6 pm. The IPO was thus over-subscribed by almost 1.4 times based on the fundraising amount of $765 million from the public offering.
KEYMED BIO-B (02162.HK), on the first day of public offering as well, recorded $21.72 billion subscription. The IPO was thus over-subscribed by almost 69 times based on the fundraising amount of $310 million from the public offering.
截至下午6點左右，券商迄今已向XPeng(09868.HK)(XPEV.US)首日公開發行的IPO授予18.3億美元保證金。因此，根據公開募股7.65億美元的籌資金額，IPO獲得了近1.4倍的超額認購。KeyMed BIO-B(02162.HK)在公開募股的第一天也獲得了217.2億美元的認購。因此，根據公開募集的3.1億美元資金，此次IPO獲得了近69倍的超額認購。